Watch LMAT. Know when insiders buy.
One email the day a filing lands. Free.
LMAT
LEMAITRE VASCULAR INC
78.87
−0.60 −0.75%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
65
PASS · shorts 65
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.8BP/E 27.7DIV YIELD 1.14%FCF YIELD 4.09%REV TTM —NET INCOME $65.7M +39.4%NET CASH —52W 78.80 – 117.39SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | $20.4M | $17.1M | +23.7% | 0.74 | $16M | $2.3M | $13.7M | Aug 5 |
| Q1 2026 · Mar 31 | — | — | — | $17.8M | $15.7M | +42.4% | 0.68 | $15.1M | $2.8M | $12.3M | Aug 5 |
| Q4 2025 · Dec 31derived | — | — | — | $18.8M | $15.6M | +39.3% | 0.68 | $23.2M | $1.8M | $21.4M | Feb 26 |
| Q3 2025 · Sep 30 | — | — | — | $20.3M | $17.4M | +55.8% | 0.75 | $28.8M | $2.3M | $26.5M | Nov 7 |
| Q2 2025 · Jun 30 | — | — | — | $16.1M | $13.8M | +16.5% | 0.60 | $20.3M | $1.3M | $18.9M | Aug 5 |
| Q1 2025 · Mar 31 | — | — | — | $12.6M | $11M | +11.4% | 0.48 | $9M | $1.4M | $7.7M | Aug 5 |
| Q4 2024 · Dec 31derived | $55.7M | +14.0% | 69.3% | $12.9M | $11.2M | +32.1% | 0.48 | $15.2M | $2M | $13.1M | Feb 26 |
| Q3 2024 · Sep 30 | $54.8M | +15.6% | 67.8% | $13.1M | $11.1M | +48.5% | 0.49 | $14.2M | $1.7M | $12.6M | Nov 7 |
| Q2 2024 · Jun 30 | $55.8M | — | 68.9% | $14.4M | $11.8M | — | 0.52 | $9.6M | $1.9M | $7.7M | Nov 7 |
| Q1 2024 · Mar 31 | $53.5M | — | 68.6% | $11.9M | $9.9M | — | 0.44 | $5.1M | $1.4M | $3.7M | Nov 7 |
| Q4 2023 · Dec 31 | $48.9M | — | 68.1% | $10.2M | $8.5M | — | 0.38 | $10.7M | $1.3M | $9.5M | Feb 26 |
| Q3 2023 · Sep 30 | $47.4M | — | 65.0% | $9.2M | $7.5M | — | 0.33 | $11.8M | $1.1M | $10.8M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $249.6M | 71.5% | $67.9M | $57.7M | 23.1% | 2.52 | $81.3M | $6.8M | $74.5M | $1.8M | $18.1M |
| FY2024 · to Dec 31 | $219.9M | 68.6% | $52.3M | $44M | 20.0% | 1.93 | $44.1M | $7M | $37.2M | $1.7M | $14.4M |
| FY2023 · to Dec 31 | $193.5M | 65.7% | $36.7M | $30.1M | 15.6% | 1.34 | $36.8M | $7.3M | $29.5M | $853K | $12.4M |
| FY2022 · to Dec 31 | $161.7M | 64.9% | $26.8M | $20.6M | 12.8% | 0.93 | $25.4M | $3.2M | $22.1M | $642K | $11M |
| FY2021 · to Dec 31 | $154.4M | 65.7% | $36.4M | $26.9M | 17.4% | 1.25 | $35.1M | $4.9M | $30.2M | $802K | $9.3M |
| FY2020 · to Dec 31 | $129.4M | 65.4% | $28.8M | $21.2M | 16.4% | 1.04 | $34.8M | $3M | $31.8M | $570K | $7.7M |
Every number comes from LEMAITRE VASCULAR INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.